Research is an important aspect of R&I Genetics' activities.

The R&I Genetics team develops both 'in-house' projects, aimed at enhancing its know-how and increasing its technical/scientific portfolio, and collaborative projects with public and/or private institutions, particularly the biomedical industry.​

The main research area is neuroscience where R&I Genetics has developed several clinical and pre-clinical research projects.

Examples of projects in which R&I Genetics was a proposer or made a significant contribution

• MIUR project Immune-inflammatory diseases of the nervous system: patho-physiological aspects and diagnostic and therapeutic development;

• Genetics of Healthy Ageing (GEHA; Sixth Framework Programme, Life Sciences, Genomics and Biotechnology for Health);

• Transcriptional study using DNA microarrays in a mouse model of amyotrophic lateral sclerosis (in collaboration with the University of Bologna);

• Identification of new pharmacogenetic markers (BIOTECH Project, Veneto Region);

• Development of new genomic technologies (BIOTECH Project, Veneto Region);

• Studies in collaboration with Hippocrates Pharmagenetics to identify pharmacogenetic markers for application to various conditions, including Crohn's disease and psoriasis;

• Project Trace amines as potential heraldic markers in Parkisnon's disease, funded by the Michael J. Fox Foundation for Parkinson Research (MJFF)